The anticancer properties of iron core-gold shell nanoparticles in colorectal cancer cells

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3321-3331

  Wu, Ya Na ^a   Wu, Ping Ching ^a   Yang, Li Xing ^a   Ratinac, Kyle R ^b   Thordarson, Pall ^d   Jahn, Kristina A ^b   Chen, Dong Hwang ^c   Shieh, Dar Bin ^a,c   Braet, Filip ^b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cancer therapy; Differential cytotoxicity; Fe; Gold coated iron; Nanoparticles

Indexed keywords

GOLD NANOPARTICLE; IRON; IRON CORE GOLD SHELL NANOPARTICLE; IRON NANOPARTICLE; METAL NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BRIGHT FIELD MICROSCOPY; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL DEATH; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MATERIAL COATING; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUTH CANCER; OXIDATION; SCANNING ELECTRON MICROSCOPY;

CANCER THERAPY; DIFFERENTIAL CYTOTOXICITY; FE; GOLD-COATED IRON; NANOPARTICLES;

APOPTOSIS; CACO-2 CELLS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; GOLD; HT29 CELLS; HUMANS; IRON; METAL NANOPARTICLES; PARTICLE SIZE;

EID: 84884577376     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S47742     Document Type: Article

References (37)

1. Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1:5358.
2. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18): 3995-4021.
3. Chen B, Wu W, Wang X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Curr Cancer Drug Targets. 2011;11(2): 184-189.
4. Shieh DB, Cheng FY, Su CH, et al. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. Biomaterials. 2005;26(34): 7183-7191.
5. Chou SW, Shau YH, Wu PC, Yang YS, Shieh DB, Chen CC. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc. 2010;132(38):13270-13278.
6. Wu PC, Wang WS, Huang YT, et al. Porous iron oxide based nanorods developed as delivery nanocapsules. Chemistry. 2007;13(14): 3878-3885.
7. Ito A, Honda H, Kobayashi T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2006;55(3):320-328.
8. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm. 2008;5(2):316-327.
9. Karlsson HL, Cronholm P, Gustafsson J, Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol. 2008;21(9): 1726-1732.
10. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol. 2003;13(6):1266-1276.
11. Carpenter EE, Sangregorio C, O'Connor CJ. Effects of shell thickness on blocking temperature of nanocomposites of metal particles with gold shells. IEEE Trans Magn. 1999;35(5):3496-3498.
12. Carpenter EE, Sims JA, O'Connor CJ. Sequential synthesis of gold coated iron nanoparticles using reverse micelles. Abstr Paper Am Chem Soc Natl Meet. 1999;218:U441.
13. 2 weighted imaging. Nanotechnology. 2006;17(3):640-644.
14. Kayal S, Ramanujan RV. Anti-cancer drug loaded iron-gold coreshell nanoparticles (Fe@Au) for magnetic drug targeting. J Nanosci Nanotechnol. 2010;10(9):5527-5539.
15. Park HY, Schadt MJ, Wang L, et al. Fabrication of magnetic core@shell Fe oxide@Au nanoparticles for interfacial bioactivity and bioseparation. Langmuir. 2007;23(17):9050-9056.
16. Kim DH, Rozhkova EA, Rajh T, Bader SD, Novosad V. Synthesis of hybrid gold/iron oxide nanoparticles in block copolymer micelles for imaging, drug delivery, and magnetic hyperthermia. IEEE Transactions, Magnetics. 2009;45(10):4821-4824.
17. Wu YN, Chen DH, Shi XY, et al. Cancer-cell-specific cytotoxicity of non-oxidized iron elements in iron core-gold shell NPs. Nanomedicine. 2011;7(4):420-427.
18. Wu YN, Yang LX, Shi XY, et al. The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondriamediated autophagy. Biomaterials. 2011;32(20):4565-4573.
19. Thurber A, Wingett DG, Rasmussen JW, et al. Improving the selective cancer killing ability of ZnO nanoparticles using Fe doping. Nanotoxicology. 2012;6(4)440-
20. Lin J, Zhou W, Kumbhar A, et al. Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic field-induced self-assembly. J Solid State Chem. 2001;159(1):26-31.
21. Ravel B, Carpenter EE, Harris VG. Oxidation of iron in iron/gold core/ shell nanoparticles. J Appl Phys. 2002;91(10):8195-8197.
22. Zhou WL, Carpenter EE, Lin J, Kumbhar A, Sims J, O'Connor CJ. Nanostructures of gold coated iron core-shell nanoparticles and the nanobands assembled under magnetic field. Eur Phys J D. 2001;16(1): 289-292.
23. Tshikhudo TR, Wang Z, Brust M. Biocompatible gold nanoparticles. Materials Science and Technology. 2004;20(8):980-984.
24. Li F, Vipulanandan C, Mohanty KK. Microemulsion and solution approaches to nanoparticle iron production for degradation of trichloroethylene. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2003;223(1-3):103-112.
25. Wu L, Shamsuzzoha M, Ritchie SMC. Preparation of cellulose acetate supported zero-valent iron nanoparticles for the dechlorination of trichloroethylene in water. J Nanopart Res. 2005;7(4-5):469-476.
26. Peng YC, Kuo HS, Tsai HD, Yang YP, Lin YL. The lethal effect of bis-type azridinylnaphthoquinone derivative on oral cancer cells (OEC-M1) associated with anti-apoptotic protein bcl-2. Bioorg Med Chem. 2006;14(1):263-272.
27. Wörle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006;6(6):1261-1268.
28. Schröterová L, Králová V, Voráčová A, Hašková P, Rudolf E, Červinka M. Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays. Toxicol In Vitro. 2009;23(7):1406-1411.
29. Allen RT, Hunter WJ 3rd, Agrawal DK. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods. 1997;37(4):215-228.
30. Tang W, Zhang Y, Qian C, Yuan Z, Du J. Induction and mechanism of apoptosis by hydroxycamptothecin in human Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci. 2012;53(8):4874-4880.
31. Vangestel C, Peeters M, Mees G, et al. In vivo imaging of apoptosis in oncology: an update. Mol Imaging. 2011;10(5):340-358.
32. Jiang L, Li X, Liu L, Zhang Q. Cellular uptake mechanism and intracellular fate of hydrophobically modified pullulan nanoparticles. Int J Nanomedicine. 2013;8:1825-1834.
33. Summers HD, Holton MD, Rees P, Williams PM, Thornton CA. Analysis of quantum dot fluorescence stability in primary blood mononuclear cells. Cytometry A. 2010;77(10):933-939.
34. Chen M, Yamamuro S, Farrell D, Majetich SA. Gold-coated iron nanoparticles for biomedical applications. J Appl Phys. 2003;93(10): 7551-7553.
35. Uboldi C, Bonacchi D, Lorenzi G, et al. Gold nanoparticles induce cytotoxicity in the alveolar type-II cell lines A549 and NCIH441. Part Fibre Toxicol. 2009;6:18.
36. Vyoral D, Petrák J. Hepcidin: a direct link between iron metabolism and immunity. Int J Biochem Cell Biol. 2005;37(9):1768-1773.
37. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275(26): 19906-19912.